Paper35106954
The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment.
Lumbers ER and 6 others. Pharmacol Res Perspect, 2022. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment. Papers, record 35106954. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35106954
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Renin-Angiotensin System | Major topic |
| SARS-CoV-2 | Major topic |
| Angiotensin Receptor Antagonists | |
| Angiotensin-Converting Enzyme 2 | |
| Angiotensin-Converting Enzyme Inhibitors | |
| Drug Repositioning | |
| Humans | |
| Inflammation | |
| COVID-19 Drug Treatment | |
| Renin Inhibitors |
Source PubMed
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11173502 | Angiotensin II-generating enzymes. | Biochemistry (Mosc) | 2000 | https://conductscience.org/library/papers/11173502 | PubMed |
| 2 | 24633843 | Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate. | Curr Hypertens Rep | 2014 | https://conductscience.org/library/papers/24633843 | PubMed |
| 3 | 8798532 | p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8798532 | PubMed |
| 4 | 28571891 | Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease. | Pharmacol Res | 2017 | https://conductscience.org/library/papers/28571891 | PubMed |
| 5 | 33120196 | Ebselen, a new candidate therapeutic against SARS-CoV-2. | Int J Surg | 2020 | https://conductscience.org/library/papers/33120196 | PubMed |
| 6 | 34078498 | Obesity and COVID-19: renin-angiotensin as a mediator of morbidity and mortality. | Br J Nutr | 2022 | https://conductscience.org/library/papers/34078498 | PubMed |
| 7 | 27070147 | Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress. | PLoS One | 2016 | https://conductscience.org/library/papers/27070147 | PubMed |
| 8 | 31901211 | The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases. | Clin Exp Pharmacol Physiol | 2020 | https://conductscience.org/library/papers/31901211 | PubMed |
| 9 | 21087212 | Renin, (pro)renin and receptor: an update. | Clin Sci (Lond) | 2011 | https://conductscience.org/library/papers/21087212 | PubMed |
| 10 | 22966141 | Human viruses: discovery and emergence. | Philos Trans R Soc Lond B Biol Sci | 2012 | https://conductscience.org/library/papers/22966141 | PubMed |
| 11 | 2266130 | Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2266130 | PubMed |
| 12 | 15151696 | ACE2 gene expression is up-regulated in the human failing heart. | BMC Med | 2004 | https://conductscience.org/library/papers/15151696 | PubMed |
| 13 | 34240733 | Soluble (pro)renin receptor: a novel ligand for angiotensin II type 1 receptor? | Clin Sci (Lond) | 2021 | https://conductscience.org/library/papers/34240733 | PubMed |
| 14 | 18474831 | Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction. | Hypertension | 2008 | https://conductscience.org/library/papers/18474831 | PubMed |
| 15 | 30978131 | Mitochondrial angiotensin receptors and cardioprotective pathways. | Am J Physiol Heart Circ Physiol | 2019 | https://conductscience.org/library/papers/30978131 | PubMed |
| 16 | 29467962 | Inflammatory responses and inflammation-associated diseases in organs. | Oncotarget | 2018 | https://conductscience.org/library/papers/29467962 | PubMed |
| 17 | 32577056 | The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role? | Med Arch | 2020 | https://conductscience.org/library/papers/32577056 | PubMed |
| 18 | 17340620 | Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung. | J Cell Biochem | 2007 | https://conductscience.org/library/papers/17340620 | PubMed |
| 19 | 4568061 | The activation of renin in human amniotic fluid by proteolytic enzymes. | Biochim Biophys Acta | 1972 | https://conductscience.org/library/papers/4568061 | PubMed |
| 20 | 17558469 | Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. | Cell Mol Life Sci | 2007 | https://conductscience.org/library/papers/17558469 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42920975 | Urotensin II: A Key Role in Hormonal and Inflammatory Cytokine Regulation in COVID-19 Patients. | Int J Microbiol | 2026 | https://conductscience.org/library/papers/42920975 | PubMed |
| 42415781 | Renin and 1-year mortality in critically ill patients with ARDS: trajectories, discrimination, and survival analysis. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42415781 | PubMed |
| 40868984 | Angiotensin-Converting Enzyme Inhibition and/or Angiotensin Receptor Blockade Modulate Cytokine Profiles and Improve Clinical Outcomes in Experimental COVID-19 Infection. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40868984 | PubMed |
| 40128651 | Modulation of RAAS receptors and miRNAs in COVID-19: implications for disease severity, immune response, and potential therapeutic targets. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/40128651 | PubMed |
| 39444690 | Possible mechanisms of SARS-CoV-2-associated myocardial fibrosis: reflections in the post-pandemic era. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39444690 | PubMed |
| 38909148 | Multicenter and multimodal imaging study reveals rare fundus lesions in patients after SARS-CoV-2 infection. | Sci Rep | 2024 | https://conductscience.org/library/papers/38909148 | PubMed |
| 38592697 | Is COVID-19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2. | J Clin Med | 2024 | https://conductscience.org/library/papers/38592697 | PubMed |
| 37998534 | The Renin-Angiotensin System: The Challenge behind Autoimmune Dermatological Diseases. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37998534 | PubMed |
| 37858626 | Discovery, validation, and prodrug design of an ACE2 activator for treating bacterial infection-induced lung inflammation. | J Control Release | 2023 | https://conductscience.org/library/papers/37858626 | PubMed |
| 37509643 | Role of the Renin-Angiotensin System in Long COVID's Cardiovascular Injuries. | Biomedicines | 2023 | https://conductscience.org/library/papers/37509643 | PubMed |
| 36985188 | Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection. | Microorganisms | 2023 | https://conductscience.org/library/papers/36985188 | PubMed |
| 36983871 | Treating COVID-19: Targeting the Host Response, Not the Virus. | Life (Basel) | 2023 | https://conductscience.org/library/papers/36983871 | PubMed |
| 36839456 | COVID-19: Diabetes Perspective-Pathophysiology and Management. | Pathogens | 2023 | https://conductscience.org/library/papers/36839456 | PubMed |
| 36755914 | RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensives. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/36755914 | PubMed |
| 36556919 | The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations. | Medicina (Kaunas) | 2022 | https://conductscience.org/library/papers/36556919 | PubMed |
| 36499094 | Schizophyllum commune Reduces Expression of the SARS-CoV-2 Receptors ACE2 and TMPRSS2. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499094 | PubMed |
| 35716247 | Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection. | Curr Hypertens Rep | 2022 | https://conductscience.org/library/papers/35716247 | PubMed |
| 35600485 | Mechanisms of Cardiovascular System Injury Induced by COVID-19 in Elderly Patients With Cardiovascular History. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35600485 | PubMed |
| 35106955 | Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID-19 and response to treatment. | Pharmacol Res Perspect | 2022 | https://conductscience.org/library/papers/35106955 | PubMed |
| 35106954 | The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment. | Pharmacol Res Perspect | 2022 | https://conductscience.org/library/papers/35106954 | PubMed |
Genes68
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35106954
GET https://conductscience.org/api/papers/v1/35106954/references?page=2